Partnerships
Facebook to use AI in predicting if Covid-19 patients need better healthcare
The sequential X-ray model can predict up to four days in advance if a patient may need intense care solutions. Read More>>
Parexel, Signify Health to improve patient access to clinical trials
The partnership will focus on improving patient access to clinical trials, bringing studies to patients in their own homes, and identifying relevant social determinants of health (SDoH) to facilitate connections among local resources, patients, and caregivers. Read More>>
Mayo Clinic, Microsoft, Epic and more join forces to improve digital COVID-19 vaccination records
The coalition was formed to address the need for a vaccination record system that allows patients to conveniently access, control and share their verifiable vaccination records. Read More>>
Recovery Unplugged goes in-network with Aetna
The partnership will enable Recovery Unplugged to increase access to its brand of lifesaving, Music-Assisted Treatment® to Aetna’s tens of millions of members, particularly those who are facing addiction within their lives and families. Read More>>
Humana, Athenahealth partnership to integrate payer data into EHRs
The five-year collaboration will focus on integrating health plan data into Athenahealth’s EHR software with the aim of supporting clinical decision making and preventing gaps in care. Read More>>
Philips joins Merck KGaA to develop AI-guided fertility treatments
Using artificial intelligence and remote patient monitoring services, the two companies hope to provide highly personalized solutions and information guiding the choice and timing of treatments to help maximize the chance of conception. Read More>>
Mergers & Acquisitions
Gastro Group of The Palm Beaches merges with Tampa General
Tampa General gastroenterology surgeons and specialists will work in collaboration with Gastro Group physicians to provide the most comprehensive treatment options in a seamless, coordinated manner. Read More>>
UPMC’s acquisition of Ireland hospital approved
The hospital will be renamed UPMC Aut Even Hospital. It will have 71 inpatient beds and an 18-bed outpatient surgery unit and offers surgical, diagnostic and medical services across 20+ specialties. Read More>>
Tenet aims to acquire up to 40 surgery centers this year
The for-profit company plans to spend $150 million or more on the surgery center acquisitions. Read More>>
Aspirus acquiring Ascension hospitals and clinics
Aspirus is acquiring seven hospitals, 21 physician clinics and Spirit Medical Transport from Ascension. Read More>>
Evolent Health enters agreement with Bright HealthCare to acquire True Health New Mexico
Once complete, current employees and leadership of True Health New Mexico will join the Bright HealthCare team and continue to lead local market operations, ensuring continuity for members, providers and distribution partners. Read More>>
Executive Movement
Spectrum Health hires new Senior VP for safety and quality
Dr. James Moses will develop and execute strategy, set targets and lead efforts for continuous improvement of quality, safety and patient experience. Read More>>
Anthem inc. names Stephen Tanal vice president, investor relations
Mr. Tanal will provide strategic leadership and execute investor relations programs that support the company’s growth strategies and enhance Anthem’s reputation with the investment community. Read More>>
RWJBarnabas Health taps Dr. Karen Marhefka as deputy CIO
Dr. Marhefka worked at healthcare technology consulting firm Impact Advisors before joining RWJBarnabas Health. Read More>>
AdventHealth names new president for central Florida division
Randy Haffner replaces Daryl Tol. He will oversee the strategic direction, development and expansion of the entire division, which includes 18 campuses across seven counties. Read More>>
Parexel appoints chief patient officer
Dr. Clare Grace has more than 20 years of experience in the CRO and biopharmaceutical industries and was recognized in 2018 by PharmaVoice as one of the top 100 most inspirational leaders in the pharmaceutical industry. Read More>>
|
|
Partnerships
Bayer partners with CureVac on coronavirus vaccine development
CureVac will hold the marketing authorization for the vaccine in the European Union (EU), while Bayer has the option to become authorization holder for markets outside the bloc. Read More>>
Novartis, GSK team up for $3.6m genetic diversity research in Africa
The collaboration is aimed at conducting scientific research linking genetic diversity in Africa and its potential impact on response to drug therapeutics. Read More>>
MyID launches partnership with Merck & Co, Inc. for KEYTRUDA® patients
MyID is an Electronic Health Record (EHR) management company that allows individuals easy access to store and manage personal health information through the company’s app-based platform. Read More>>
Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout
The collaboration is aimed at determining whether herd immunity is achieved after reaching a certain percentage of vaccination coverage in Israel. Read More>>
Syntekabio signs joint development agreement with Hanmi Science
Syntekabio will also collaborate with Hanmi Science to drive clinical development for its proprietary COVID-19 treatments and subsequent drug repositioning research including clinical development and regulatory affairs. Read More>>
Centre Setup and Expansion
Cytiva delivers modular biologics factory to Lonza
The 17,000 sqm site includes 6500 sqm of lab space and one KUBio modular facility, and will enable ramp-up of antibody development services and manufacturing, needed to respond to market needs for biologics, including mAbs and other complex proteins. Read More>>
Merger and Acquisitions
Merck’s acquisition of AmpTec GmbH
The acquisition strengthens Merck’s capabilities to develop and manufacture mRNA for its customers (inter alia over 50 vaccine manufacturers) for the potential use in vaccines, treatments and diagnostics applicable for Covid-19 and many other diseases. Read More>>
Laurus Labs completes acquisition of 72.55% stake in Richcore Lifesciences
Richcore brings significant expertise in enzyme development for pharmaceutical and other industrial applications. Read More>>
Catalent agrees to acquire dry powder inhaler spray drying, capsule manufacturing, and packaging capabilities from Acorda Therapeutics
The acquisition complements Catalent’s status as a premier U.S.-based partner for companies across dry powder inhaled dose forms. Read More>>
Executive Movement
Biocon chief appointed new vice-chair of US-India biz body
Kiran Mazumdar-Shaw will forge collaborative initiatives in pharma and healthcare in research, innovation and skill development between the two countries. Read More>>
Dr. Richard Woodman appointed chief clinical officer of the oncology business group at Eisai Inc.
Dr. Woodman will have full oversight and responsibility for the strategic and operational leadership of the company’s global oncology clinical development functions, including clinical research, clinical operations, imaging, medical writing, data services, biostatistics and regulatory strategy. Read More>>
Deals
Novartis lays out $650M-plus for BeiGene’s tislelizumab as its own PD-1 fails to impress
Novartis is not abandoning its own checkpoint inhibitor spartalizumab despite a recent phase 3 trial failure; instead, it views the two PD-1s as “complementary”. Read More>>
|
|
Merger & Acquistions
Integra LifeSciences completes the acquisition of ACell
With this acquisition, Integra will be able to provide more comprehensive complex wound management solutions to address its customers’ most pressing clinical challenges. Read More>>
Boston Scientific bets on cardiac wearables with $925M Preventice buy
Preventice gives Boston Scientific a larger presence in the growing cardiac monitoring market, which should also help the company’s long-term insertable cardiac monitoring products. Read More>>
Haemonetics to buy bloodstopper medtech Cardiva Medical in $510M deal
Both devices employ a collapsible disc in different sizes to deliver a collagen patch to stop blood loss that is later resorbed by the body as the wound heals. Read More>>
Philips to acquire Capsule Technologies in $635M deal
The acquisition will continue Philip’s efforts to move beyond healthcare facilities by complementing its real-time patient monitoring and remote care offerings. Read More>>
Thermo Fisher Scientific to acquire point-of-care molecular diagnostics provider Mesa Biotech
Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Read More>>
Thermo Fisher buys Henogen for nearly $880 million in gene therapy expansion
Henogen, a unit of contract manufacturing services provider Novasep, manufactures viral vectors that are frequently used in gene therapies to deliver genetic materials into defective cells. Read More>>
Partnerships
EXACT Therapeutics announces innovative probe development collaboration with GE Healthcare
This collaboration with GE Healthcare is to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT®) across multiple disease conditions. Read More>>
Bola Technologies and Henry Schein One announce partnership
The partnership will enable Henry Schein One to market and sell Bola AI’s Voice Perio solution to Dentrix and Dentrix Ascend customers. Read More>>
Siemens Healthineers POCcelerator data management system now connects to HLS Therapeutics Inc. CSAN ProntoTM
The CSAN Pronto is a point of care device that uses capillary (finger stick) as opposed to venous blood draw to simplify the process of routine bloodwork for patients on Clozaril® (clozapine), a therapeutic for people with Treatment Resistant Schizophrenia. Read More>>
Executive Movement
Miguel O. Beltrán-Delgado joins Bioventus as senior vice president of operations
Miguel has more than 24 years of experience in operations, quality and manufacturing . He will be responsible for creating a vision for continual improvement of operations including driving productivity, reducing cycle times and optimizing the company’s manufacturing and supply chain footprint. Read More>>
Agilent names Allison Ballmer Senior vice president of strategy and corporate development
Ballmer will lead the corporate development team in identifying, developing, and evaluating merger-and-acquisition plans globally, as well as program management of integrations. Read More>>
Product Launch
Abbott to launch the NeuroSphere™ myPath™ digital health app
The app will allow patients to record their pain relief during the device trial period with spinal cord stimulation or dorsal root ganglion therapy, simplify reporting outcomes and connect patients to physicians who have real-time access to this data. Read More>>
Boston Scientific launches WaveWriter Alpha™ spinal cord stimulator systems in U.S.
The WaveWriter Alpha SCS Systems are supported by Cognita Solutions to address common challenges in pain management, including raising awareness about drug-free pain management options, helping patients find local physicians, and helping physicians sustain functional outcomes for patients over the long-term. Read More>>
|
|
|
Headlines From The Startup World
|
|
|
|
Latest Insights & Reports
|
|
|
Here’s what’s new on our Sales Intelligence Platform
View Number of ‘Active Workflows’
|
|
|
View the number of active workflows with each service provider in the outsourcing section to assess the relationship strength.
|
|
|
|
|
|
